Atul Pande, Director at Sio Gene Therapies, holds 114.41K shares in Immunovant (Ticker: IMVT), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX), holds 33.37K shares in Sio Gene Therapies (Ticker: SIOX).

See the Hottest Stocks Based on Insider Trading >

Atul Pande
Sio Gene Therapies (SIOX)
Director

Ranked #6,513 out of 98,624 Corporate Insiders

Profitable Transactions

2 out of 6 Profitable Transactions

Average Return

+47.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

IMVT

A breakdown of Atul Pande's holdings

See the Top Stocks by Insiders

Insider Roles

Immunovant
(IMVT)

Director

Roles that Atul Pande holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Immunovant
(IMVT)

Rating:Informative Buy

Date:Oct 04, 2022 - Oct 04, 2023

Return:+316.20%

The most profitable trade made by Atul Pande

See the Latest Stocks Traded by Insiders

Atul Pande's Trading History

SIOX

Sio Gene Therapies

Nov 25, 2020

―

Informative Buy

23.30K

$15.95K

KRTX

Karuna Therapeutics

Mar 18, 2024

―

Uninformative Sell

326.70K

$0.00

IMVT

Immunovant

Apr 04, 2024

Director

Uninformative Buy

―

$3.30M

List of latest transactions for each holding click on a transaction to see Atul Pande's performance on stock

See All Insider Trading from Today

Atul Pande insider profile FAQ

What is the percentage of profitable transactions made by Atul Pande?

The percentage of profitable transactions made by Atul Pande is 33%.

What is the average return per transaction made by Atul Pande?

The average return per transaction made by Atul Pande is 47.80%.

What stocks does Atul Pande hold?

Atul Pande holds: SIOX, KRTX, IMVT stocks.

What was Atul Pande’s latest transaction?

Atul Pande latest transaction was an Uninformative Buy of ―.

What was Atul Pande's most profitable transaction?

Atul Pande’s most profitable transaction was an Informative Buy of IMVT stock on October 4, 2022. The return on the trade was 316.20%.

What is Atul Pande's role in Sio Gene Therapies?

Atul Pande's role in Sio Gene Therapies is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Atul Pande Insider Profile

Atul Pande Sio Gene Therapies (SIOX)Director